Therapie des hepatozellulären Karzinoms-Reference-Cited by-同舟云学术

Therapie des hepatozellulären Karzinoms

Published:2013-11-17 Issue:1 Volume:55 Page:23-30
ISSN:0020-9554
Container-title:Der Internist
language:de
Short-container-title:Internist

Author:

Wörns M.A.,Klöckner R.,Weinmann A.,Galle P.R.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00108-013-3318-4.pdf

Reference30 articles.

1. Bolondi L, Burroughs A, Dufour JF et al (2012) Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 32:348–359

2. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

3. Burrel M, Reig M, Forner A et al (2012) Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design. J Hepatol 56:1330–1335

4. Cainap C, Qin S, Huang WT et al (2013) Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC). J Clin Oncol 30 (Suppl 34):Abstract 249

5. Cheng AL, Kang Y, Lin D et al (2011) Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC). J Clin Oncol 29 (Suppl):Abstract 4000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Das hepatozelluläre Karzinom;best practice onkologie;2018-01-30

2. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma;Tumor Biology;2017-06

3. Das hepatozelluläre Karzinom;Der Internist;2017-04-06

4. Liver resection for intermediate hepatocellular carcinoma;World Journal of Hepatology;2016

5. Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma;PLOS ONE;2015-05-26